Analytical Validation of the Oncotype DX Genomic Diagnostic Test for Recurrence Prognosis and Therapeutic Response Prediction in Node-Negative, Estrogen Receptor–Positive Breast Cancer - Concepedia

Concepedia

Publication | Open Access

Analytical Validation of the Oncotype DX Genomic Diagnostic Test for Recurrence Prognosis and Therapeutic Response Prediction in Node-Negative, Estrogen Receptor–Positive Breast Cancer

DOI Full Paper Access

344

Citations

26

References

2007

Year

Maureen Cronin, Chithra Sangli, Mei‐Lan Liu, Mylan Pho, Debjani Dutta, Anh Nguyen, Jennie Jeong, Jenny Wu, Kim M. Clark-Langone, Drew Watson

Clinical Chemistry

Abstract

The analytical and operational performance specifications defined for the Oncotype DX assay allow the reporting of quantitative RS values for individual patients with an SD within 2 RS units on a 100-unit scale.

References

	Year	Citations

Page 1